NEWS
New Study Reveals Racial Disparity in Alzheimer's Trial Eligibility
April 24th, 2024
Solanezumab: The Future of Alzheimer's Medication?
January 1st, 2024
Alzheimer's Disease in Down Syndrome – A CTAD '23 Talk Recap
November 10th, 2023
FAQ: Why Would I Participate in an AD Clinical Trial or Study?
August 2nd, 2023
Revolutionizing Alzheimer's Clinical Trials with ATRI EDC
May 15th, 2023